EUVIMEDDescubrir EUVIMED
Video/Audio

Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics Analysis

Julia Franz, Fabian Freitag, Patrick Ho, Theodor Bormann, Michael Hudecek, Maik Luu

Journal of Visualized Experiments · 2026

DOI: 10.3791/69702 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Julia Franz and 5 co-authors. Institution: Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg. Major MEDLINE topics: Receptors, Chimeric Antigen, T-Lymphocytes, Microfluidic Analytical Techniques, Single-Cell Analysis. 14 references.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Adoptive T-cell therapy is a novel treatment paradigm in which autologous T cells are genetically modified to express a tumor-targeting chimeric antigen receptor (CAR) prior to ex vivo expansion and re-infusion into the patient. Despite remarkable demonstrations of anti-tumor potency in patients with advanced hematological malignancies, long-lasting responses fail to manifest in a substantial fraction of cases. Although several idiosyncratic factors may contribute to the variability in clinical outcomes, there is mounting evidence that the percentage of polyfunctional T cells in the pre-infusion CAR-T cell product strongly correlates with the durability of cancer remission. Unfortunately, standard evaluations of CAR-T cell products currently rely on bulk population measurements or terminal assays, limiting the ability to isolate and study sub-populations with heightened functional properties. Here, we demonstrate a workflow that leverages an optofluidics platform to evaluate both the cytokine secretion profile and activation via CD137 expression of individual CAR-T cells, which can be optionally combined with cytotoxic activity assessment. Cells exhibiting the greatest degree of multimodal functionality can be isolated for further analyses to inform the design of next-generation CAR-T cell therapies.

Subjects

MeSH terms (MEDLINE)

Receptors, Chimeric AntigenT-LymphocytesMicrofluidic Analytical TechniquesSingle-Cell AnalysisReceptors, Antigen, T-CellHumansImmunotherapy, AdoptiveTumor Necrosis Factor Receptor Superfamily, Member 9Cytokines

Substances

Receptors, Chimeric AntigenTumor Necrosis Factor Receptor Superfamily, Member 9Receptors, Antigen, T-CellCytokines

Authors and institutions

  • Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg.
  • Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg; Außenstelle Zelluläre Immuntherapie, Fraunhofer Institut für Zelltherapie und Immunologie (IZI).
  • Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg; Außenstelle Zelluläre Immuntherapie, Fraunhofer Institut für Zelltherapie und Immunologie (IZI); Luu_M@kw.de.

Cite

APA

Franz, J., Freitag, F., Ho, P., Bormann, T., Hudecek, M., & Luu, M. (2026). Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics Analysis. Journal of Visualized Experiments. https://doi.org/10.3791/69702

Vancouver

Franz J, Freitag F, Ho P, Bormann T, Hudecek M, Luu M. Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics Analysis. Journal of Visualized Experiments. 2026. doi:10.3791/69702

BibTeX
@article{Franz2026,
  author = {Franz, Julia and Freitag, Fabian and Ho, Patrick and Bormann, Theodor and Hudecek, Michael and Luu, Maik},
  title = {Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics Analysis},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/69702}
}
Start for free →